Scott Ward chairs the Remuneration Committee and serves on the Nomination Committee. Scott is Chairman of the Board, President and CEO of Cardiovascular Systems Inc. and a Managing Director of SightLine Partners.
Scott has over 30 years of experience in the healthcare industry, including nearly 30 years at Medtronic Inc. He was the Senior Vice President and President of the Cardiovascular business of Medtronic Inc., responsible for all worldwide operations of the Cardiovascular Business including the Coronary, Peripheral, Endovascular, Structural Heart Disease and Revascularization and Surgical Therapies businesses. Previously, Scott served as Senior Vice President and President of Medtronic Neurological and Diabetes, with responsibility for the global Neurological, Neurologic Technologies, Diabetes, Gastroenterology and Urology businesses; Vice President and General Manager of the Medtronic Drug Delivery Business; and Director of Medtronic NeuroVentures.
Scott is also the Founder of RAymond Holding, LLC a firm with activities in venture capital, strategy and transactional advisory services. He holds a Bachelor’s Degree in Genetics and Cell Biology, and a Masters Degree in Toxicology, both from the University of Minnesota.
Scott’s 35+ years of experiece in the healthcare industry, including his significant leadership experience of public medical device companies and his prior service on the boards of public medical device companies, make him a valuable contributor to the Board.
|COMPANY NAME||APPOINTED||RETIRED / RESIGNED|
|ImpediMed Limited||July 13||–|
|Surmodic Incorporated (i)||September 10||March 15|
|Cardiovascular Systems Incorporated (i)||November 13||–|
(i) US-based publicly traded company.